TP53 and neoplasm: However, due to the heterogeneous subpopulations that develop during the process of tumor progression, some significant markers such as TERT, TP53, ARID2, ARID1A, and the WNT signaling regulator CTNNB1 cannot be targeted efficiently, which reduces the utility of the predictor from a treatment perspective.